PRReleasevia Quantisnow
Janux Therapeutics Inc. logo

Janux Therapeutics to Host Virtual Event Discussing Updated Phase 1a and Phase 1b Clinical Data for JANX007 in mCRPC

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Keep researching JANX

Quantisnow market dataNASDAQ
Janux Therapeutics Inc. logo
JANX
Janux Therapeutics Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2021
Get push alerts for JANX

Follow JANX and get a push notification the moment its next story breaks.

Full JANX profile on Quantisnow

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track JANX (Janux Therapeutics Inc.) and more on Quantisnow.